Precision Biologic has announced an update of its Cryocheck Chromogenic Factor VIII assay, a test used to help diagnose and ...
Objective This study examined the patterns and persistence of SARS-CoV-2 seropositivity among college students from March to ...
A Cornell-led collaboration has devised a potentially low-cost method for producing antibodies for therapeutic treatments. They've bioengineered bacteria with an overlooked enzyme that can attach ...
First-in-human trial shows promising results for antibody-drug conjugate in relapsed small cell lung cancer by International Association for the Study of Lung Cancer edited by Sadie Harley, reviewed ...
Hosted on MSN
First-in-human trial shows promising results for antibody-drug conjugate in relapsed small cell lung cancer
A first-in-human Phase I study of SHR-4849 (IDE849), a Delta-like ligand 3 (DLL3)-directed antibody-drug conjugate (ADC), demonstrated manageable safety and early signs of anti-tumor activity in ...
First-in-Human Trial Shows Promising Results for DLL3-Targeted Antibody-Drug Conjugate SHR-4849 in Relapsed Small Cell Lung Cancer (Barcelona, Spain Sunday, September 7, 2025 at 4:45 PM CEST / UTC +2) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback